Unlocking the therapeutic potential of bioactive compounds in Ganoderma lucidum: a new frontier in natural medicine
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989100%3A27360%2F25%3A10258921" target="_blank" >RIV/61989100:27360/25:10258921 - isvavai.cz</a>
Výsledek na webu
<a href="https://link.springer.com/article/10.1007/s13205-025-04353-y" target="_blank" >https://link.springer.com/article/10.1007/s13205-025-04353-y</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s13205-025-04353-y" target="_blank" >10.1007/s13205-025-04353-y</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Unlocking the therapeutic potential of bioactive compounds in Ganoderma lucidum: a new frontier in natural medicine
Popis výsledku v původním jazyce
Ganoderma lucidum (Reishi), a valued medicinal fungus used in traditional medicine for over 2000 years, has sparked widespread scientific attention due to its extensive range of bioactive ingredients and therapeutic promise in modern medicine. This study presents a detailed and up-to-date examination of G. lucidum's primary bioactive components, which include polysaccharides, triterpenoids, meroterpenoids, nucleotides, proteins, alkaloids, and sesquiterpenoids. These chemical components show a wide range of pharmacological effects, including immune modulation, cancer suppression, and neuroprotection. The review also gives insight on developing and underexplored therapeutic areas, such as the mushroom's antiviral properties particularly its anti-HIV potential as well as its anti-fibrotic, neuropharmacological, and anti-aging benefits. By combining traditional therapeutic knowledge with modern biomedical innovation, G. lucidum is positioned as a viable natural resource for solving modern health issues. Continued study is required to understand the molecular processes that underpin its many effects and to assist its incorporation into evidence-based medicinal applications. It subsequently emphasizes and thoroughly examines G. lucidum's bioactive components, as well as insights into its rising role in healthcare, combining traditional knowledge with recent biological achievements.
Název v anglickém jazyce
Unlocking the therapeutic potential of bioactive compounds in Ganoderma lucidum: a new frontier in natural medicine
Popis výsledku anglicky
Ganoderma lucidum (Reishi), a valued medicinal fungus used in traditional medicine for over 2000 years, has sparked widespread scientific attention due to its extensive range of bioactive ingredients and therapeutic promise in modern medicine. This study presents a detailed and up-to-date examination of G. lucidum's primary bioactive components, which include polysaccharides, triterpenoids, meroterpenoids, nucleotides, proteins, alkaloids, and sesquiterpenoids. These chemical components show a wide range of pharmacological effects, including immune modulation, cancer suppression, and neuroprotection. The review also gives insight on developing and underexplored therapeutic areas, such as the mushroom's antiviral properties particularly its anti-HIV potential as well as its anti-fibrotic, neuropharmacological, and anti-aging benefits. By combining traditional therapeutic knowledge with modern biomedical innovation, G. lucidum is positioned as a viable natural resource for solving modern health issues. Continued study is required to understand the molecular processes that underpin its many effects and to assist its incorporation into evidence-based medicinal applications. It subsequently emphasizes and thoroughly examines G. lucidum's bioactive components, as well as insights into its rising role in healthcare, combining traditional knowledge with recent biological achievements.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
10600 - Biological sciences
Návaznosti výsledku
Projekt
—
Návaznosti
O - Projekt operacniho programu
Ostatní
Rok uplatnění
2025
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
3 Biotech
ISSN
2190-572X
e-ISSN
2190-5738
Svazek periodika
15
Číslo periodika v rámci svazku
7
Stát vydavatele periodika
DE - Spolková republika Německo
Počet stran výsledku
21
Strana od-do
nestránkováno
Kód UT WoS článku
001503363400001
EID výsledku v databázi Scopus
—